Shanghai Institute Materia Medica, Chinese Academy Of Sciences;Topharman Shanghai Co., Ltd.;Suzhou Vigonvita Life Sciences Co., Ltd.
发明人:
申请号：
EP18827841.0
公开号：
EP3650444A4
申请日:
2018.07.02
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a salt of phenyl pyrimidinone compound, a polymorph thereof and a pharmaceutical composition comprising the same and a use thereof, particularly relates to the hydrochlorate of phenyl pyrimidinone compound of following formula (I-A) and a pharmaceutically acceptable polymorph, solvate, hydrate, co-crystal, anhydrous substance, or amorphous form thereof, a pharmaceutical composition and a pharmaceutical unit dosage comprising the same, the preparing method and use thereof.
